Bernal-Bello, D., Jaenes-Barrios, B., Morales-Ortega, A., Ruiz-Giardin, J. M., García-Bermúdez, V., Frutos-Pérez, B., . . . San Martín-López, J. V. (2020). Imatinib might constitute a treatment option for lung involvement in COVID-19. Autoimmun Rev.
Chicago Style CitationBernal-Bello, David, et al. "Imatinib Might Constitute a Treatment Option for Lung Involvement in COVID-19." Autoimmun Rev 2020.
Cita MLABernal-Bello, David, et al. "Imatinib Might Constitute a Treatment Option for Lung Involvement in COVID-19." Autoimmun Rev 2020.
Atenció: Aquestes cites poden no estar 100% correctes.